BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/27/2018 4:40:10 AM | Browse: 1357 | Download: 2321
Publication Name World Journal of Hepatology
Manuscript ID 39458
Country Russia
ISSN 1948-5182 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Aberrant expression of alternative isoforms of transcription factors in hepatocellular carcinoma
Manuscript Source Unsolicited Manuscript
All Author List Olga Krivtsova, Anna Makarova and Natalia Lazarevich
ORCID
Author(s) ORCID Number
Olga Krivtsova http://orcid.org/0000-0002-0207-2724
Anna Makarova http://orcid.org/0000-0002-9711-9256
Natalia Lazarevich http://orcid.org/0000-0001-9560-1383
Funding Agency and Grant Number
Funding Agency Grant Number
Russian Foundation for Basic Research 18-34-00816\18
Corresponding Author Natalia Lazarevich, DSc, PhD, Professor, Federal State Budgetary Institution, “N. N. Blokhin Medical Research Center of Oncology” of the Ministry of Health of the Russian Federation, 24/15 Kashirskoye sh., Moscow 115478, Russia. lazarevich.nl@gmail.com
Key Words Alternative isoforms; Transcription factors; Hepatocellular carcinoma; Alternative splicing; Hepatic differentiation; Personalized treatment
Core Tip This paper aims to analyze existing data on the spectrum of isoforms of liver-specific transcription factors produced in the liver and hepatocellular carcinoma (HCC) and implicated in carcinogenesis, their distinct regulatory functions and subsequent isoform-dependent biological effects which may be relevant for tumor progression and clinical outcomes in HCC patients.
Publish Date 2018-10-27 04:40
Citation Krivtsova O, Makarova A, Lazarevich N. Aberrant expression of alternative isoforms of transcription factors in hepatocellular carcinoma. World J Hepatol 2018; 10(10): 645-661
URL http://www.wjgnet.com/1948-5182/full/v10/i10/645.htm
DOI http://dx.doi.org/10.4254/wjh.v10.i10.645
Full Article (PDF) WJH-10-645.pdf
Full Article (Word) WJH-10-645.doc